search
Back to results

Ultrasound-guided vs. Blinded Dry Needling for Piriformis Syndrome

Primary Purpose

Piriformis Syndrome

Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Ultrasound-guided dry needling
Blinded dry needling
Sponsored by
Uskudar State Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Piriformis Syndrome

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Male or female patients aged 18-65 years. Clinical diagnosis of piriformis syndrome based on the following criteria: buttock pain, radiating pain to the posterior thigh, and tenderness over the piriformis muscle. Pain intensity of at least 4 out of 10 on a visual analog scale (VAS). Willingness to comply with the study protocol and provide informed consent. Exclusion Criteria: Previous surgery or injection therapy for piriformis syndrome. Contraindications to dry needling, such as bleeding disorders or skin infections. Pregnancy or breastfeeding. History of neurological disorders, such as sciatica, radiculopathy, or neuropathy. History of serious psychiatric illness or substance abuse. Inability to complete the study questionnaires or follow-up assessments.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Active Comparator

    Active Comparator

    Arm Label

    Ultrasound-guided dry needling group

    Blinded dry needling group

    Arm Description

    Patients in this group will receive dry needling for piriformis syndrome under real-time ultrasound guidance.

    Patients in this group will receive dry needling for piriformis syndrome without ultrasound guidance.

    Outcomes

    Primary Outcome Measures

    Change in Visual Analog Scale for Pain
    A Visual Analog Scale (VAS) for pain is a commonly used tool to measure the intensity of pain experienced by a patient. It typically consists of a horizontal or vertical line, typically 10 centimeters long, with endpoints labeled as "no pain" and "worst possible pain." The patient is asked to mark on the line the point that best represents the intensity of their pain, with the distance from the "no pain" end of the line to the patient's mark representing the pain score.
    Change in Oswestry Disability Index (ODI)
    The Oswestry Disability Index (ODI) is a self-administered questionnaire that is widely used to assess the functional status of patients with low back pain or sciatica. The ODI consists of 10 sections, each relating to a different aspect of functional impairment, such as pain intensity, personal care, lifting, walking, sitting, standing, sleeping, social life, traveling, and employment/homemaking. Each section is scored on a scale of 0-5, with a total score ranging from 0 (no disability) to 50 (complete disability). The ODI is a validated and reliable tool for assessing functional status and has been used in many clinical trials to evaluate the effectiveness of interventions for low back pain or sciatica.

    Secondary Outcome Measures

    Full Information

    First Posted
    May 7, 2023
    Last Updated
    May 20, 2023
    Sponsor
    Uskudar State Hospital
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT05882799
    Brief Title
    Ultrasound-guided vs. Blinded Dry Needling for Piriformis Syndrome
    Official Title
    Ultrasound-guided vs. Blinded Dry Needling for Piriformis Syndrome: A Randomized Trial
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    May 2023
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    July 1, 2023 (Anticipated)
    Primary Completion Date
    December 1, 2023 (Anticipated)
    Study Completion Date
    February 1, 2024 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Uskudar State Hospital

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    This randomized controlled trial aims to compare the effectiveness of ultrasound-guided versus blinded dry needling for the treatment of piriformis syndrome.
    Detailed Description
    This randomized controlled trial aims to compare the efficacy of ultrasound-guided versus blinded dry needling for the treatment of piriformis syndrome. Patients in both groups will receive three weekly sessions of dry needling performed by a single experienced physiatrist. The intervention will involve inserting a sterile acupuncture needle into the trigger points of the piriformis muscle and manipulating the needle to elicit a twitch response. Patients in the ultrasound-guided group will receive dry needling under real-time ultrasound guidance, while patients in the blinded group will receive dry needling without ultrasound guidance. Patients will be assessed before treatment, after treatment, after the third week, and after three months.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Piriformis Syndrome

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Model Description
    Randomized Trial
    Masking
    Outcomes Assessor
    Masking Description
    The outcomes assessor will be blinded.
    Allocation
    Randomized
    Enrollment
    60 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Ultrasound-guided dry needling group
    Arm Type
    Active Comparator
    Arm Description
    Patients in this group will receive dry needling for piriformis syndrome under real-time ultrasound guidance.
    Arm Title
    Blinded dry needling group
    Arm Type
    Active Comparator
    Arm Description
    Patients in this group will receive dry needling for piriformis syndrome without ultrasound guidance.
    Intervention Type
    Procedure
    Intervention Name(s)
    Ultrasound-guided dry needling
    Intervention Description
    Ultrasound-guided dry needling is a minimally invasive technique that involves inserting a sterile acupuncture needle into trigger points of a muscle while monitoring the needle's progress with real-time ultrasound imaging. In this technique, a trained practitioner visualizes the piriformis muscle and the surrounding structures using an ultrasound machine, and then inserts the needle through the skin and into the muscle tissue, guided by the ultrasound image.
    Intervention Type
    Procedure
    Intervention Name(s)
    Blinded dry needling
    Intervention Description
    Blinded dry needling is a minimally invasive technique that involves inserting a sterile acupuncture needle into trigger points of a muscle without using real-time imaging guidance. In this technique, the practitioner relies solely on their palpation skills to locate the trigger points of the piriformis muscle and inserts the needle through the skin and into the muscle tissue.
    Primary Outcome Measure Information:
    Title
    Change in Visual Analog Scale for Pain
    Description
    A Visual Analog Scale (VAS) for pain is a commonly used tool to measure the intensity of pain experienced by a patient. It typically consists of a horizontal or vertical line, typically 10 centimeters long, with endpoints labeled as "no pain" and "worst possible pain." The patient is asked to mark on the line the point that best represents the intensity of their pain, with the distance from the "no pain" end of the line to the patient's mark representing the pain score.
    Time Frame
    First day, after three weeks, after three months
    Title
    Change in Oswestry Disability Index (ODI)
    Description
    The Oswestry Disability Index (ODI) is a self-administered questionnaire that is widely used to assess the functional status of patients with low back pain or sciatica. The ODI consists of 10 sections, each relating to a different aspect of functional impairment, such as pain intensity, personal care, lifting, walking, sitting, standing, sleeping, social life, traveling, and employment/homemaking. Each section is scored on a scale of 0-5, with a total score ranging from 0 (no disability) to 50 (complete disability). The ODI is a validated and reliable tool for assessing functional status and has been used in many clinical trials to evaluate the effectiveness of interventions for low back pain or sciatica.
    Time Frame
    First day, after three weeks, after three months

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    65 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Male or female patients aged 18-65 years. Clinical diagnosis of piriformis syndrome based on the following criteria: buttock pain, radiating pain to the posterior thigh, and tenderness over the piriformis muscle. Pain intensity of at least 4 out of 10 on a visual analog scale (VAS). Willingness to comply with the study protocol and provide informed consent. Exclusion Criteria: Previous surgery or injection therapy for piriformis syndrome. Contraindications to dry needling, such as bleeding disorders or skin infections. Pregnancy or breastfeeding. History of neurological disorders, such as sciatica, radiculopathy, or neuropathy. History of serious psychiatric illness or substance abuse. Inability to complete the study questionnaires or follow-up assessments.
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Mustafa H Temel, M.D.
    Phone
    +905342714872
    Email
    mhuseyintemel@gmail.com
    First Name & Middle Initial & Last Name or Official Title & Degree
    Fatih Bağcıer, M.D.
    Phone
    05442429042
    Email
    bagcier_42@hotmail.com
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Mustafa H Temel, M.D.
    Organizational Affiliation
    Uskudar State Hospital
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Plan to Share IPD
    Yes
    IPD Sharing Plan Description
    Individual participant data will be shared upon reasonable request by the corresponding author.
    IPD Sharing Time Frame
    1 month.
    IPD Sharing Access Criteria
    Individual participant data will be shared upon reasonable request by the corresponding author.

    Learn more about this trial

    Ultrasound-guided vs. Blinded Dry Needling for Piriformis Syndrome

    We'll reach out to this number within 24 hrs